Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction

European Journal of Health Economics

Volumn 7, Issue 4, 2006, Pages 247-254

  Gerber, A ^a   Evers, T ^a   Haverkamp, H ^a   Lauterbach, K W ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cholesterol reduction; Coronary heart disease; Cost benefit analysis; Low fat margarine; Low fat plant sterol

Indexed keywords

CHOLESTEROL; MARGARINE; PHYTOSTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; FOOD INTAKE; GERMANY; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROBABILITY; RISK FACTOR; RISK REDUCTION; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGED; CHOLESTEROL; CORONARY DISEASE; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MARGARINE; MARKOV CHAINS; META-ANALYSIS; MIDDLE AGED; MODELS, ECONOMETRIC; PHYTOSTEROLS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 33847299664     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-006-0363-0     Document Type: Article

References (54)

1. Hinzpeter B, Klever-Deichert G, Wendland G, Lauterbach KW (2000) Die koronare Herzkrankheit und die Sozialversicherung. Herz 25: 515-525
2. Wiesner G, Grimm J, Bittner E (1999) Zum Herzinfarktgeschehen in der Bundesrepublik Deutschland: Prävalenz, Inzidenz, Trend, Ost-West-Vergleich. Gesundheitswesen 61: S72-S78
3. Klever-Deichert G, Hinzpeter B, Wendland G, Lauterbach KW (2000) Kosten-Nutzen-Analyse einer evidenzbasierten Sekundärprävention koronarer Herzkrankheiten durch Statine. Med Klin 95: 305-313
4. Anonymous (2002) Morbidity & mortality: 2002 chart book on cardiovascular, lung, and blood diseases. Health NIo.
5. Anderson KM, Odell PM, Wilson PWF, Kannel WB (1991) Cardiovascular disease risk profiles. Am Heart J 121: 293-298
6. Assmann G, Schulte H (1990) Modelling the Helsinki Heart Study by means of risk equations obtained from the PROCAM Study and the Framingham Heart Study. Drugs 40: 13-18
7. Wood D, De Backer G, Faergeman O et al. (1998) Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 140: 199-270
8. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): National Heart, Lung, and Blood Institute. National Institutes of Health
9. Grundy SC, Balady GJ, Criqui MH et al. (1998) Primary prevention of coronary heart disease: guidance from Framingham. Circulation 97: 1876-1887
10. Sowers JR, Reed J (2000) 1999 Clinical advisory treatment of hypertension and diabetes. J Clin Hypertens 2: 132-133
11. Berlin J, Colditz G (1990) A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 132: 612-628
12. Eaton CB (1992) Relation of physical activity and cardiovascular fitness to coronary heart disease. I. A meta-analysis of the independent relation of physical activity and coronary heart disease. J Am Board Fam Pract 5: 31-42
13. Hooper L, Summerbell CD, Higgins JPT, Thompson RL, Capps NE, Smith GD et al (2001) Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ 322: 757-763
14. Schaefer EJ (2002) Lipoproteins, nutrition, and heart disease. Am J Clin Nutr 75: 191-212
15. Tang JL, Armitage JM, Lancaster T et al. (1998) Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. BMJ 316 1213-1220
16. Cater NB, Grundy SM (1998) Lowering serum cholesterol with plant sterols and stanols. Historical perspectives. Postgrad Med [Special Report]: 5-14
17. Ling WH, Jones PJ (1995) Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci 57: 195-206
18. Ostlund RE Jr (2002) Phytosterols in human nutrition. Annu Rev Nutr 22: 533-549
19. Salen G, Ahrens EH, Grundy SM (1970) Metabolism of beta-sitosterol in man. J Clin Invest 49: 952-967
20. McGee D, Gordon T (2000) The Framingham Study applied to four other U.S. based epidemiological studies of cardiovascular disease. United States Department of Health, Education and Welfare, NIH, Framingham Study, section no. 31: 1976
21. Bellach BM, Knopf H, Thefeld W (1998) Der Bundes-Gesundheitssurvey 1997/98. Gesundheitswesen 60 [Suppl 2]: S59-S68
22. Thierfelder W, Seher CH, Thefeld W (1998) Der Bundes-Gesundheitssurvey. 1997/98-Untersuchungsteil. Gesundheitswesen 60 [Suppl 2]: S69-S77
23. Ntanios F (2001) Spreads enriched with plant sterol esters lower blood total and LDL cholesterol but not HDL cholesterol levels: a meta-analysis of Unilever studies. Vlaardingen: Unilever Research
24. Ayesh R, Weststrate JA, Drewitt PN, Hepburn PA (1999) Safety evaluation of phytosterol esters. V. Faecal short-chain fatty acid and microflora content, faecal bacterial enzyme activity and serum female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. Food Chem Toxicol 37: 1127-1138
25. Hendriks HF, Brink EJ, Meijer GW et al. (2003) Safety of long-term consumption of plant sterol esters-enriched spread. Eur J Clin Nutr 57: 681-692
26. Jones PJ, Raeini-Sarjaz M, Ntanios FY et al. (2000) Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 41: 697-705
27. Maki KC, Davidson MH, Umporowicz DM et al. (2001) Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program step I diet. Am J Clin Nutr 74: 33-43
28. Mussner MJ, Parhofer KG, Von Bergmann K et al. (2002) Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake. Metabolism 51: 189-194
29. Neil HA, Meijer GW, Roe LS (2001) Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis 156: 329-337
30. Noakes M, Clifton P, Ntanios F et al. (2002) An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr 75: 79-86
31. Tijburg L, Meijer G, Rudrum M, Ntanios F (2001) Plant sterol-esters in a low fat spread are efficacious in lowering blood cholesterol levels in normal cholesterolemic subjects. FASEB J 15: A397
32. Weststrate JA, Meijer GW (1998) Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 52: 334-343
33. Hwang JS (1999) Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies. Stat Med 18: 1627-1640
34. Wendland G (2002) Kosteneffektivitätsanalyse der Statintherapie zur Primärprävention der koronaren Herzkrankheit in Deutschland. Thesis, University of Cologne
35. Ruckdäschel S, Berger K, Szucs T (1996) Koronare Herzkrankheit - ein sozioökonomisches Problem? Munch Med Wochenschr 138: 40-44
36. Pearce KA, Furberg CD, Psaty BM, Kirk J (1998) Cost-minimization and the number needed to treat in uncomplicated hypertension. Am J Hypertens 11: 618-629
37. Katan MB, Grundy SM, Jones P et al., for the Stresa Workshop Participants (2003) Efficacy and safety of plants stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78: 965-978
38. Pollak OJ (1985) Effects of plant sterols on serum lipids and atherosclerosis. Pharmacol Ther 31: 177-208
39. Hendriks HF, Weststrate JA, van Vliet T, Meijer GW (1999) Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 53: 319-327
40. Scientific Committee on Food (SCF) (2002) General view of the Scientific Committee on Food on the long-term effects of the intake of elevated levels of phytosterols from multiple dietary sources, with particular attention to the effects on β-carotene. http://europa.eu.int/comm/food/fs/sc/scf/index_en. html, accessed 26 September 2002
41. Awad AB, Fink CS (2000) Phytosterols as anticancer dietary components: evidence and mechanism of action. J Nutr 139: 2127-2130
42. Normen L, Andersson SW (2004) Does phytosterol intake affect the development of cancer? In: Dutta PC (ed) Phytosterols as functional food components and nutraceuticals. Nutraceutical science and technology. New York: Dekker
43. Assmann G, Paul Cullen P, Erbey J et al. (2005) Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr Metab Cardiovasc Dis 15: 373-381
44. Glueck CJ, Speirs J, Tracy T et al. (1991) Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolaemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolaemic probands and their first-degree relatives. Metabolism 40: 842-848
45. Sutherland WHF, Williams WJA, Nye ER et al. (1998) Associations of plasma noncholesteriol sterol levels with severity of coronary artery disease. Nutr Metab Cardiovasc Dis 8: 386-391
46. Rajaratnam RA, Gylling H, Miettinen TA (2000) Independent association of serum squalene and noncholesterol sterol with coronary artery disease in postmenopausal women. J Am Coll Cardiol 35: 1185-1191
47. Sudhop T, Gottwald BM, Bergmann K von (2002) Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism 51: 1519-1521
48. Wilund KR, Yu L, Xu F et al. (2004) No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterioscler Thromb Vasc Biol 24: 2326-2332
49. Lauterbach KW, Gerber A, Stollenwer B et al. (2005/2006) Die Bedeutung der Therapie mit Lipidsenkern für die kardiovaskuläre Prävention aus gesundheitsökonomischer Sicht. In: Bundesärztekammer (ed) Fortschritte und Fortbildung in der Medizin, vol 29. Cologne: Deutscher Ärzte, pp 236-244
50. Simons LA (2002) Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia. Am J Cardiol 90: 737-740
51. Phillips C, Belsey J, Shindler J (2000) Flora proactiv: a clinical and financial impact analysis. J Med Econ 3: 61-76
52. Law M (2000) Plant sterol and stanol margarines and health. BMJ 320: 861-864
53. Law MR, Wald NJ, Thompson SG (1994) By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 308: 367-372
54. Lichtenstein AH, Deckelbaum RJ (2001) AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 103: 1177-1179